Skip to main content

Market Overview

UPDATE: Jefferies Initiates Coverage on Rollins at Buy on Recurring Revenues


In a report published on Wednesday, Jefferies analyst Dan Dolev initiated coverage on Rollins (NYSE: ROL) with a Buy rating and a price target of $28.

In the report, Jefferies stated, "Near term, rising healthcare costs may boost roll-ups. Most (50-90%) bed-bug clients are incremental, which can boost cross-selling. Longer term, we see a ~$30bn global opportunity and 200-500 margin upside."

Rollins closed on Wednesday at $24.33.

Latest Ratings for ROL

Oct 2020StifelMaintainsHold
Jul 2020RBC CapitalMaintainsSector Perform
Feb 2020BuckinghamMaintainsNeutral

View More Analyst Ratings for ROL
View the Latest Analyst Ratings


Related Articles (ROL)

View Comments and Join the Discussion!

Posted-In: Dan Dolev Jefferies NYSE RollinsAnalyst Color Initiation Analyst Ratings

Latest Ratings

OSPNSidoti & Co.Upgrades39.0
PLTSidoti & Co.Upgrades48.0
LRCXArgus ResearchMaintains725.0
ROSTLoop CapitalMaintains145.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at